Exploitation of methylthioribose kinase in the development of antiprotozoal drugs.
Fitchen
J H
JH
Medical Research Service, Portland V.A. Medical Center, OR.
Riscoe
M K
MK
Ferro
A J
AJ
D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D003114:Colony-Forming Units Assay; D056890:Eukaryota / Q000187:drug effects / Q000201:enzymology*; D006801:Humans; D051379:Mice; D010770:Phosphotransferases / Q000378:metabolism*; D017853:Phosphotransferases (Alcohol Group Acceptor); D013865:Thioglycosides / Q000494:pharmacology
D000981:Antiprotozoal Agents; D013865:Thioglycosides; C001955:5-methylthioribose; C060023:5-S-ethyl-5-thioribose; D010770:Phosphotransferases; D017853:Phosphotransferases (Alcohol Group Acceptor); C021787:5-methylthioribose kinase